You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百濟神州(06160.HK)續漲10%屢創紀錄高 獲券商升價及安進斥4.21億美元參與配股
阿思達克 07-15 11:02
百濟神州(06160.HK)獲美國生物公司安進斥4.21億股參與配股行動,加上大摩及里昂分別調高目標價至140元及134元,評級分別為「增持」及「跑贏大市」。該股承昨天逆市急漲近13%破頂勢,今早進一步升至162.3元屢創紀錄高,現造151.1元,續漲10%,成交額9,608萬元。

美國生物科技公司安進(Amgen)表示,將額外投資4.21億美元參與百濟神州配股,令其持股維持於20.3%水平,公司指投資反映對內地腫瘤科合作進展有信心。

百濟神州本周一表示,擬以每股約110.29元(較上周五本港收市價折讓7.6%),配售1.46億股或佔擴大後股本12.54%,所得款項淨額約160.4億港元,將用作營運資金及其他一般公司用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account